nsc 664704 has been researched along with Acute Confusional Senile Dementia in 2 studies
kenpaullone: inhibits CDK1/cyclin B; structure in first source
kenpaullone : An indolobenzazepine that is paullone in which the hydrogen at position 9 is replaced by a bromo substituent. It is an ATP-competitive inhibitor of cyclin-dependent kinases (CDKs) and glycogen synthase kinase 3beta (GSK3beta).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Indirubins were recently described as potent (IC(50): 50-100 nm) inhibitors of cyclin-dependent kinases (CDKs)." | 1.31 | Indirubins inhibit glycogen synthase kinase-3 beta and CDK5/p25, two protein kinases involved in abnormal tau phosphorylation in Alzheimer's disease. A property common to most cyclin-dependent kinase inhibitors? ( Bibb, JA; Biernat, J; Eisenbrand, G; Garnier, M; Greengard, P; Hoessel, R; Leclerc, S; Mandelkow, EM; Marko, D; Meijer, L; Snyder, GL; Wu, YZ, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Leost, M | 1 |
| Schultz, C | 1 |
| Link, A | 1 |
| Wu, YZ | 2 |
| Biernat, J | 2 |
| Mandelkow, EM | 2 |
| Bibb, JA | 2 |
| Snyder, GL | 2 |
| Greengard, P | 2 |
| Zaharevitz, DW | 1 |
| Gussio, R | 1 |
| Senderowicz, AM | 1 |
| Sausville, EA | 1 |
| Kunick, C | 1 |
| Meijer, L | 2 |
| Leclerc, S | 1 |
| Garnier, M | 1 |
| Hoessel, R | 1 |
| Marko, D | 1 |
| Eisenbrand, G | 1 |
2 other studies available for nsc 664704 and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
Paullones are potent inhibitors of glycogen synthase kinase-3beta and cyclin-dependent kinase 5/p25.
Topics: Adenosine Triphosphate; Alzheimer Disease; Animals; Apoptosis; Benzazepines; Binding, Competitive; C | 2000 |
Indirubins inhibit glycogen synthase kinase-3 beta and CDK5/p25, two protein kinases involved in abnormal tau phosphorylation in Alzheimer's disease. A property common to most cyclin-dependent kinase inhibitors?
Topics: Adenosine Triphosphate; Alkaloids; Alzheimer Disease; Animals; Antibiotics, Antineoplastic; Calcium- | 2001 |